Per-Peptide HPLC Verification on Every Batch Each component is HPLC-checked against its own method and reference standard with a 99% release threshold, then re-confirmed by mass spectrometry
Alternatively, finding that the proportion of patients using antihypertensive medications and the distribution of different antihypertensive agents (and of their different combinations) were comparable between groups can be taken to suggest that data were very unlikely confounded by concomitant BP-lowering therapy, even if it was not standardized
Reporting Adverse Events or Safety Concerns If you experience or suspect an adverse event, contamination, or quality issue with this product, report it immediately to: Hospira Pfizer: Manufacturer contact information available on the product vial FDA MedWatch: 1-888-SAFEMED (1-888-723-3633) or online at fda.gov/medwatch Poison Control: 1-800-222-1222 (for toxicology guidance) Your institutional pharmacovigilance system: If you work for a hospital, clinic, or healthcare institution Regulatory Compliance By purchasing and using this product, you agree to comply with all applicable FDA regulations, state pharmacy laws, and professional licensing requirements
doi: 10.1080/1028415X.2018.1478766
